AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 247 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $368,932 | +425.4% | 4,583 | +420.8% | 0.01% | +200.0% |
| Q1 2024 | $70,224 | -86.5% | 880 | -86.5% | 0.00% | -66.7% |
| Q4 2023 | $519,405 | +1201.5% | 6,526 | +1042.9% | 0.01% | +500.0% |
| Q3 2023 | $39,907 | -44.1% | 571 | -42.5% | 0.00% | -50.0% |
| Q2 2023 | $71,357 | +142614.0% | 993 | +21.8% | 0.00% | 0.0% |
| Q1 2023 | $50 | +85.2% | 815 | +141.1% | 0.00% | +100.0% |
| Q4 2022 | $27 | -100.0% | 338 | -98.7% | 0.00% | -94.7% |
| Q3 2022 | $1,173,000 | +2246.0% | 26,291 | +1928.6% | 0.02% | +1800.0% |
| Q2 2022 | $50,000 | +150.0% | 1,296 | +170.0% | 0.00% | – |
| Q1 2022 | $20,000 | -50.0% | 480 | -54.3% | 0.00% | -100.0% |
| Q4 2021 | $40,000 | -28.6% | 1,051 | -38.0% | 0.00% | 0.0% |
| Q3 2021 | $56,000 | -45.6% | 1,695 | +10.4% | 0.00% | -66.7% |
| Q2 2021 | $103,000 | -56.0% | 1,536 | -62.7% | 0.00% | -25.0% |
| Q1 2021 | $234,000 | +175.3% | 4,122 | +296.3% | 0.00% | +33.3% |
| Q4 2020 | $85,000 | -92.1% | 1,040 | -93.1% | 0.00% | -75.0% |
| Q3 2020 | $1,070,000 | +207.5% | 15,006 | +255.2% | 0.01% | -14.3% |
| Q2 2020 | $348,000 | +2220.0% | 4,225 | +2774.1% | 0.01% | +1300.0% |
| Q4 2019 | $15,000 | -81.2% | 147 | -96.3% | 0.00% | -80.0% |
| Q3 2019 | $80,000 | -76.7% | 3,923 | -70.6% | 0.01% | -78.3% |
| Q2 2019 | $344,000 | +11366.7% | 13,352 | +1403.6% | 0.02% | – |
| Q4 2018 | $3,000 | 0.0% | 888 | -16.1% | 0.00% | – |
| Q2 2018 | $3,000 | -57.1% | 1,059 | -60.7% | 0.00% | -100.0% |
| Q1 2018 | $7,000 | +600.0% | 2,697 | +1000.8% | 0.00% | – |
| Q4 2017 | $1,000 | – | 245 | – | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2017 | $16,000 | +300.0% | 4,170 | +766.9% | 0.00% | – |
| Q2 2016 | $4,000 | -33.3% | 481 | -31.4% | 0.00% | -100.0% |
| Q1 2016 | $6,000 | +100.0% | 701 | +116.4% | 0.00% | – |
| Q4 2015 | $3,000 | – | 324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |